Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 10;3(1):e207.
doi: 10.1017/ash.2023.480. eCollection 2023.

Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center

Meghan E Cook  1 , Brian R Schuler  1 , Michael J Schontz  1 , Kevin C McLaughlin  1 , Kenneth E Lupi  1 , Jeremy R DeGrado  1 , Chanu Rhee  2   3
Affiliations

Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center

Meghan E Cook et al. Antimicrob Steward Healthc Epidemiol. .

Abstract

Objective: To evaluate the prevalence, risk factors, and clinical impact of delays in second doses of antibiotics in patients with sepsis.

Design: Single-center, retrospective, observational study.

Setting: Large teaching hospital.

Patients: Adult patients who triggered an electronic sepsis alert in the emergency department (ED), received ≥2 doses of vancomycin or an antipseudomonal beta-lactam, and were discharged with an ICD-10 sepsis code.

Methods: We assessed the prevalence of delays in second doses of antibiotics by ≥25% of the recommended dose interval and conducted multivariate regression analyses to assess for risk factors for delays and in-hospital mortality.

Results: The cohort included 449 patients, of whom 123 (27.4%) had delays in second doses. In-hospital death occurred in 31 patients (25.2%) in the delayed group and 71 (21.8%) in the non-delayed group (p = 0.44). On multivariate analysis, only location in a non-ED unit at the time second doses were due was associated with delays (OR 2.75, 95% CI 1.20-6.32). In the mortality model, significant risk factors included malignant tumor, respiratory infection, and elevated Sequential Organ Failure Assessment (SOFA) score but not delayed second antibiotic doses (OR 1.19, 95% CI 0.69-2.05). In a subgroup analysis, delayed second doses were associated with higher mortality in patients admitted to non-intensive care units (ICUs) (OR 4.10, 95% CI 1.32-12.79).

Conclusions: Over a quarter of patients with sepsis experienced delays in second doses of antibiotics. Delays in second antibiotic doses were not associated with higher mortality overall, but an association was observed among patients admitted to non-ICUs.

PubMed Disclaimer

Conflict of interest statement

M.C., B.S., M.S., K.M., K.L., and J.D. report no conflicts of interest relevant to this article.

Figures

Figure 1.
Figure 1.
Study flowchart. Abbreviations: ED, emergency department; BWH, Brigham and Women’s Hospital; BPA, best practice alert.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021;49:e1063–e1143. doi: 10.1097/CCM.0000000000005337 - DOI - PubMed
    1. Chiu C, Legrand M. Epidemiology of sepsis and septic shock. Curr Opin Anaesthesiol. 2021;34:71–76. doi: 10.1097/ACO.0000000000000958 - DOI - PubMed
    1. Rhee C, Yu T, Wang R et al. Association between implementation of the severe sepsis and septic shock early management bundle performance measure and outcomes in patients with suspected sepsis in US hospitals. JAMA Netw Open 2021;4:e2138596. doi: 10.1001/jamanetworkopen.2021.38596 - DOI - PMC - PubMed
    1. Kumar A, Roberts D, Wood KE et al.. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9 - DOI - PubMed
    1. Ferrer R, Artigas A, Suarez D et al.. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009;180:861–866. doi: 10.1164/rccm.200812-1912OC - DOI - PubMed

LinkOut - more resources